plerixafor has been researched along with Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avogaro, A; Bonora, BM; Bruttocao, A; Cappellari, R; Fadini, GP; Grasso, M; Mazzucato, M; Menegolo, M; Rigato, M | 1 |
| Avogaro, A; Cappellari, R; D'Anna, M; Fadini, GP | 1 |
2 trial(s) available for plerixafor and Diabetes Mellitus
| Article | Year |
|---|---|
Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: A phase IIa, randomized, double-blind, placebo-controlled trial.
Topics: Aged; Benzylamines; Cyclams; Diabetes Mellitus; Double-Blind Method; Female; Hematopoietic Stem Cell Mobilization; Humans; Male; Placebos; Treatment Outcome; Wound Healing | 2020 |
Plerixafor improves the endothelial health balance. The effect of diabetes analysed by polychromatic flow cytometry.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Benzylamines; Chemokine CXCL12; Cyclams; Diabetes Mellitus; Endothelial Cells; Endothelial Progenitor Cells; Endothelium, Vascular; Female; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Leukocyte Common Antigens; Male; Middle Aged; Regeneration; Stem Cells; Treatment Outcome; Young Adult | 2016 |